Fred Hoch’s Post

TechNexus is actively tracking 1,000+ early stage startups in Chicago, and in our new #ReinventingIndustry series we’re breaking them down by sector, starting with Chicago's #healthtech venture landscape. At nearly 10%, healthtech accounts for the highest volume of early-stage companies funded in Chicago. All founded in the last ten years, this collection of startups has raised over $400 million in total, according to Pitchbook. Dive into the full market map and stay tuned for more industry breakdowns in the weeks to come. 👇 ✍ Joey Alfieri Jim Dallke

Chicago has all the ingredients for a thriving healthtech ecosystem: Large corporations, major hospital systems, industry-specific accelerators, and a thriving crop of early stage startups leading major innovations in the healthcare space. Read more from TechNexus Venture Collaborative's Joey Alfieri on the state of early stage healthtech startups in Chicago 👇

As one of the most active early stage investors in Chicago and operator of TeamWorking by TechNexus, the largest single coworking space in the city, we at TechNexus Venture Collaborative are actively tracking over 1,000 early stage Chicago ventures across all industries. In our newest series, Reinventing Industry: Mapping the Venture Landscape of Chicago, we’re highlighting the largest and most disruptive categories seeing local venture activity. To start, we examined the Chicago-based innovators in healthtech — which features companies building AI-powered imaging/diagnostic tools, digital health platforms, and novel medical devices, to name a few verticals. These young startups benefit from surrounding infrastructure like medtech accelerators (MATTER, mHUB ), incumbent corporate leaders (AbbVie, Walgreens, Baxter International Inc.), hospital systems (Northwestern Memorial Hospital, Rush University Medical Center, Endeavor Health), cutting edge research universities (Northwestern University, University of Chicago), and leading venture / PE firms (venture: 7wire Ventures, 2Flo Ventures | PE: Shore Capital Partners, Thoma Bravo) focused on the space. Read the full breakdown linked below, and stay tuned for the next overview of the energy / sustainability landscape!

Altris AI is on the Venture Landscape Map of Chicago as one of the innovators in healthtech. Yet, it is unique in building an AI-powered OCT scan analysis platform as a decision-making support tool for eye care professionals.

Explore insights from OCV Partners' Chris Bostick and Thea Pham on investing in tech and health care startups, showcasing their commitment to innovation and diversity

⁉️Let's flip the script for a moment: We’ve explored how venture capital (#VC) fuels innovation and growth in healthcare and delved into expert insights on Portfolio Management and #Investment Thesis Design. ⤵️ What if we consider the reverse pitch concept? This approach provides a unique perspective on what venture capitalists seek in healthcare #startups and emerging #technologies. Understanding this can offer invaluable insights and boost your know-how early in your entrepreneurial journey. Ken Nelson, Partner at ADVANTAGE MEDTECH LIMITED, lead the conversation with Sanchita Pasi | Bhavesh Barot, Operating Partner & CBO, Truffle Capital | Amir Soltanianzadeh, Founder & Managing Partner, Solardis Health Ventures | Enric Claverol , PhD, Head of the Medical Technologies Programme, European Commission | Julien L. Pham, MD, MPH, Founder & Managing Partner, 3CC | Third Culture Capital | Linus Rieder, Principal, 415 Capital | GREG MADDEN, Managing Partner, SV Health Investors. 📌 Check out their input: https://lnkd.in/d4vsBdpZ

On Point: Innovation & Startups Bryan Dechairo on his role as a Life Science's CEO. - “I’ve raised millions of dollars of venture capital.” Is that a credential? Or a qualification for leadership? Why do we see it so often. It feels like the wrong destination. - That’s the thing we love about scientists. They can’t help being scientists – even if they are a venture funded CEO. And so often, they’re tied to a strong desire to improve the human condition. - This is Brian Dechairo’s description of himself. Scientist first. Passionate about the way healthcare is developed and delivered. Excited by the opportunity to decentralize testing and improve global health. - Pretty easy to want to be on that team. - Watch this video https://bit.ly/4a0xLcR Watch the full episode https://bit.ly/3RtVXvR Sherlock Biosciences MassMEDIC

CIC (Cambridge Innovation Center), a global leader in building and operating innovation communities, and Persephoni BioPartners, a strategic advisory and Biotech venture studio firm, are excited to announce a strategic partnership built around CIC Philadelphia’s location in uCity Square to drive growth and development of early-stage biotech companies in Philadelphia. “We are incredibly excited to call CIC our home for our Philadelphia operations. Their state of the art facilities will enable our current portfolio companies to accelerate their research and development as we prepare for clinical advancement. We aim to serve across the ecosystem and facilitate cross organizational and institutional collaborations to serve the amazing technologies housed within Philadelphia,” said Hilary Schultz, CEO of Persephoni BioPartners Persephoni has an office on the 7th floor of CIC Philadelphia at 3675 Market Street in the uCity Square Knowledge Community, where it will serve as a landing pad for the companies in its venture studio program. It will also open its doors to existing CIC members, offering advisory services ranging from startup incorporation and capitalization table structure, strategic planning, regulatory strategy, capital raise, and business development to support strategic partnerships. Read more on the CIC Blog! https://lnkd.in/gVxqqmHW

Angel Match highlights the top healthcare venture capital firms helping to drive innovation in Colorado's healthtech sector. Investors like QED Investors and Sophris Ventures are putting their capital behind promising startups solving modern healthcare challenges. With substantial investments, these firms are key players in Colorado’s startup ecosystem, offering support to companies across healthcare, tech, and beyond. Read the full story for more data on the specific firms leading this space. https://lnkd.in/e8hHsDrT #HealthTech

Celebrating a Decade of Deep Tech Success. As WNT Ventures marks 10 years of strategic investments in New Zealand's innovation ecosystem, we take pride in our investment portfolio and our partnership with Callaghan Innovation as the longest-running Deep Tech Incubator in New Zealand. Together, we've nurtured groundbreaking deep tech startups that are transforming industries and driving economic growth and invested alongside some iconic New Zealand and overseas Venture Capital Funds. Our journey has been about more than just funding—it's been about fostering innovation, supporting diverse founders, and creating sustainable pathways for growth in Aotearoa. With three funds in deployment and multiple realised returns, we are excited about what the next 10 years will bring. See below some of our reflections and what we've achieved over the last decade. #deeptech #wntventures #callaghaninnovation #venturecapital Carl, Maria Jose, Niamh, TJ, Anna. Foundry Lab, Mastaplex, Avertana, Mint Innovation, TDRI, Marama Labs, Insite AI, Arcanum AI, Sortify.tm, Periomedic, SoundSwitch, CarbonCrop, Hairspace, Iaso Automated Medical Systems Limited, PhaseFoam Limited, Bspkl, Goodair Nosebuds, Hale Animal Health, Opo Bio, EatKinda, Apercure. https://lnkd.in/gntXXB8G